Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2024.679 | Passive sensing and detection of mood features using affective computing technology |
Dr. LI Man Ho Man Ho Li |
| 2024.500 | Harnessing machine learning to predict adherence to a fully automated digital cognitive behavioral therapy for insomnia (CBT-I) | Dr. LI Man Ho |
| 2024.455 | Utilizing generative artificial intelligence, deep learning, and prompt engineering for the development of digital depression assessment |
Dr. LI Man Ho Man Ho Li |
| 2024.612 | An Intelligent Coaching System for Insomnia: Towards the Next-generation Digital Intervention | Prof. LI Man Ho |
| 2021.547 | Efficacy of a chatbot to deliver cognitive-behavioral therapy for insomnia in youth: A randomized controlled trial | Dr. LI Man Ho |
| 2023.668 | Smartphone voice-based ecological momentary assessment for depression recurrence: A prospective cohort study of patients with remitted major depressive disorder | Dr. LI Man Ho |
| 2022.478 | Evaluation of a Multicomponent Mental Health Promotion Program | Dr Li Man Ho |
| 2024.078 | Evaluation of an Artificial Intelligence chatbot for sleep education | Dr. LI Man Ho |
| 2023.504 | Development of automated speech-based suicidal ideation detection with Artificial Intelligence techniques | Dr. LI Man Ho |
| 2023.536 | Multimodal digital speech analysis for detection of depressive symptomatology in youth |
Dr. LI Man Ho Man Ho Li |
| 2022.013 | Efficacy of sleep-focused artificial intelligence chatbot for youth with insomnia: An assessor-blind, randomized controlled trial | Dr. LI Man Ho |
| 2022.592 | Efficacy of digital cognitive behavioral therapy for insomnia (CBT-I) with artificial intelligence chatbot for youth with insomnia: An assessor-blind, randomized controlled trial | Dr. LI Man Ho |
| 2021.295 | Rotational alignment of the femoral trochlear in Asian and its implication on implant choice for managing isolated patellofemoral arthritis: A retrospective magnetic resonance imaging study |
Dr. LI Michelle Kar Lam 李家琳 |
| 2021.453 | Prevalence and Impact on Quality of Life of Urinary incontinence among Chinese Women in Primary Care Setting | Dr. LI Ming Yin |
| 2015.194 | Metabolite level of 15-lipoxygenases in serum of Chinese non-small cell lung cancer patients: A non-invasive predictor to screen recurrence and metastasis after treatments |
Dr. LI Ming Yue 李明月 |
| 2016.216 | Down-regulated expression of 15-lipoxygenases in lung cancer in never-smokers |
Prof. LI Ming Yue 李明月 |
| 2019.374 | The effectiveness of WeChat couple-based psychosocial intervention (WCBPI) on sexual function, relationship satisfaction, dyadic coping and quality of life of gynaecological cancer patients and their partners: A mixed method study |
Ms. LI Minjie 李敏捷 |
| 2022.338 | A Pilot Study in Development of Tissue Sparing Imaging with Virtual Immunohistochemical stain for Lung Cancer Diagnosis via Deep Learning |
Dr LI Molly 李兆澄 |
| 2022.571 | A Phase 2 Platform Study Evaluating the Safety and Efficacy of Novel Treatment Combinations in Patients With Lung Cancer (VELOCITY-Lung) Substudy-02: Patients With Disease Progression After Receiving Systemic Treatment for Non-Small-Cell Lung Cancer (NSCLC) |
Dr. LI Molly Siu Ching 李兆澄醫生 |
| 2023.649 | A PHASE III, RANDOMIZED, DOUBLE-BLIND STUDY OF TIRAGOLUMAB PLUS ATEZOLIZUMAB COMPARED WITH PLACEBO PLUS ATEZOLIZUMAB IN PARTICIPANTS WITH COMPLETELY RESECTED STAGE IIB, IIIA, OR SELECT IIIB, PD-L1 POSITIVE, NON-SMALL CELL LUNG CANCER WHO HAVE RECEIVED ADJUVANT PLATINUM-BASED CHEMOTHERAPY | Dr. LI Molly Siu Ching |
| 2023.654 | An Open-Label, Phase 2b, Global Multicenter Cohort Trial to Assess the Safety and Efficacy of Zipalertinib in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Exon 20 Insertion and Uncommon/Single or Compound Epidermal Growth Factor Receptor Mutations | Dr. LI Molly Siu Ching |
| 2023.149 | A Phase II, Open-label, Single-arm, Multi-centre Study to Evaluate the Safety and Efficacy of Osimertinib with Amivantamab as First-line Treatment in Participants with Epidermal Growth Factor Receptor Mutation-Positive, Locally Advanced or Metastatic Non-small Cell Lung Cancer (OSTARA) |
Dr. LI Molly Siu Ching 李兆澄 醫生 |
| 2024.064 | A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) who Have not Progressed Following Concurrent Chemoradiation Therapy (DeLLphi-306) | Dr. LI Molly Siu Ching |
| 2023.642 | LC-SHIELD (Lung Cancer Screening in HIgh risk nonsmokErs by artificial inteLligence Device) | Dr. LI Molly Siu Ching |
| 2022.392 | A Randomized, Open-Label, Phase 3 Study to Evaluate Zimberelimab and Domvanalimab in Combination with Chemotherapy Versus Pembrolizumab With Chemotherapy for the First-Line Treatment of Patients With Metastatic Non–Small Cell Lung Cancer With No Epidermal Growth Factor Receptor or Anaplastic Lymphoma Kinase Genomic Tumor Aberrations | Dr. LI Molly Siu Ching |
| 2024.183 | A Phase 1b/2, multicenter, open-label platform study of select immunotherapy combinations in adult participants with previously untreated advanced non-small cell lung cancer (NSCLC) with high PD-L1 expression | Dr. LI Molly Siu Ching |
| 2024.456 | A Phase 2, Open-Label, Single-Arm Study of Amivantamab and Lazertinib Combination Therapy as First-Line Treatment in Patients with EGFR-Mutated Recurrent Non-Small Cell Lung Cancer after Previous Treatment with Adjuvant Osimertinib in Early-Stage Disease | Dr. LI Molly Siu Ching |
| 2024.230 | A PHASE III, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF DIVARASIB VERSUS SOTORASIB OR ADAGRASIB IN PATIENTS WITH PREVIOUSLY TREATED KRAS G12C-POSITIVE ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER | Dr. LI Molly Siu Ching |
| 2024.171 | A Phase 3, Open-label, Multicenter, Randomized Study of Tarlatamab in Combination With Durvalumab vs Durvalumab Alone in Subjects with Extensive-Stage Small-Cell Lung Cancer Following Platinum, Etoposide and Durvalumab (DeLLphi-305) | Dr. LI Molly Siu Ching |
| 2024.271 | A randomized, multicenter, double-blind, Phase 3 study to investigate the safety and efficacy of belrestotug in combination with dostarlimab compared with placebo in combination with pembrolizumab in participants with previously untreated, unresectable, locally advanced or metastatic PD-L1-selected non-small-cell lung cancer (GALAXIES LUNG-301) | Dr. LI Molly Siu Ching |
| 2024.174 | A Phase 2 Platform Study Evaluating the Safety and Efficacy of Novel Treatment Combinations in Patients With Lung Cancer (VELOCITY-Lung) Substudy-01: Patients With No Prior Systemic Treatment for Metastatic Non–Small-Cell Lung Cancer (mNSCLC) | Dr. LI Molly Siu Ching |
| 2024.636 | A Phase 1/2 Open-Label, Multicenter, First-In-Human Study of the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of BH-30643 in Adult Subjects with Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations (SOLARA) | Dr. LI Molly Siu Ching |
| 2019.514 | EBBI, the key to excellent functional outcome in Chinese paediatric patients with lower extremity bone sarcoma | Dr . LI Moses Man Lung |
| 2011.051 | Evaluation of Quality of Care – Haemodialysis Public-Private-Partnership, HA | Prof. LI Philip |
| 2016.672 | Developing Gistful Thinking and Cognitive Flexibility among High-Functioning Adolescents with Autism Spectrum Disorder |
Mr. LI Philip Hung Kong 李鴻鋼 |
| 2010.015 | Management of Diabetes Patients in a Primary CARE Setting - Health-Related Quality of Life and Anxiety Scores | Professor Li Philip Kam-tao |
| 2019.086 | The effects of an empowerment-based cognitive behavioural therapy for insomnia on sleep, cognitive function and health-related quality of life in persons with mild cognitive impairment: A waitlist randomized controlled trial | Prof. LI Polly Wai Chi |
| 2018.430 | Psychometric evaluation of the Chinese version of the Atrial Fibrillation Effect on QualiTy-of-Life questionnaire and the Atrial Fibrillation Knowledge Scale | Prof. LI Polly Wai Chi |
| 2017.410 | The experience of patients and family caregivers in managing pneumoconiosis in the family context: An exploratory qualitative study | Prof. LI Polly Wai Chi |
| 2017.595 | Promoting brain health among people with suboptimal cognitive functioning in Hong Kong: A Brain Vitality Enhancement (BRAVE) program | Prof. LI Polly Wai Chi |
| 2016.419 | Low back pain self-management: evaluation of an intensive in-patient low back pain education program for female elderly with low back pain: A cohort study |
Miss LI Pui Man 李佩雯 |
| 2024.084 | Validation of the Chinese Fall Efficacy Scale (FES) | Ms. LI Pui Man |
| 2009.468 | Effect of a modified Tai Chi exercise on quality of life, anxiety and deprssion among stroke patients: a quasi-experimental study | Mr Li Pui On |
| 2016.546 | Eye-hand Coordination, Visual Attention, and Physical Activity in Children with Cerebral Palsy |
Miss LI Ru 李如 |
| 2023.590 | A randomized controlled trial of an acceptance and commitment therapy-based parenting program for improving parenting stress and other health outcomes of parents and children with autism spectrum disorder |
Miss. LI Sini 李斯妮 |
| 2023.101 | Effect of IL24-expressing mesenchymal stem cells on immune system in lung cancer patients and health donors |
Dr. LI Siu Ching 李兆澄 |
| 2023.099 | Neoadjuvant Sacituzumab Govitecan plus Pembrolizumab in Resectable Non-Small Cell Lung Cancer: an open-label, multicenter, single arm phase 2 study |
Dr. LI Siu Ching 李兆澄 |
| 2022.364 | Investigating the genomic landscape and evolution and its impact on clinical outcome in ALK-positive non-small cell lung cancer |
Dr. LI Siu Ching 李兆澄 |
| 2022.236 | Evaluation of Immune Tumour Microenvironment of EGFR mutation positive NSCLC after Osimertinib treatment |
Dr. LI Siu Ching 李兆澄 |
| 2022.253 | Establishment of New Territories East Cluster Lung Cancer Database |
Dr. LI Siu Ching 李兆澄 |
Page 151 of 262.